The Valley Desk

NCT02005315 · Interventional trial

A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer

Overall registry status Completed

Phase 1

Conditions Pancreatic Cancer, Stage IV Pancreatic Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov